Date Type of Proceeding
Issued Case (1) or App'n No. Party/Parties
11-15 EX 75/339,348 Biovector
Therapeutics, S.A.
11-15 EX 75/366,221 PageMart,
(R) Inc.
Opposer's/ Applicant's/
Petitioner's Respondent's
TTAB Mark and Mark and
Issue Decision Goods/Services Goods/Services
2(e)(1); Refusal "BIOVECTOR"
genericness; Reversed [pharmaceutical
whether as to Rule preparations,
applicant 2.61(b) namely, drug
failed to requirement and delivery systems,
comply with genericness; drug carriers,
requests under application pharmaceutical
Rule 2.61(b) remanded for excipients, drug
further adjuvants, drug
consideration activators and
of Section drug penetration
2(e)(1), in enhancers; and
view of pharmaceutical
possible preparations
submission of used for neurology,
Sec. 2(f) pain, cancer,
evidence immunotherapy,
vaccines, namely,
DNA vaccines,
autoimmune disease,
hormonotherapy,
endocrinology,
anti-infectious,
cardiology,
deficiency disease,
rheumatology,
allergy, otorhino-
laryngolgy,
pneumology,
ophthalmology,
gene therapy and
diagnostics;
pharmaceutical
research and
development
services for
others]
2(d) Request for "SCOUT"
Reconsideration [message pagers
Denied and personal
[Refusal communication
Affirmed systems, namely,
(but only as to two-way pagers;
the cited mark and two-way pager
SCOUT for cards]
wireless
microphones and
receivers)]
Mark and Citable as
Goods Cited by Precedent
Examining Atty. of TTAB
No
"SCOUT" No
[digital computers]
and
"SCOUT"
[wireless microphones and
wireless receivers]
(1)EX=EX PARTE APPEAL; OPP=OPPOSITION; CANC=CANCELLATION; CU=CONCURRENT
USE; (SJ)=SUMMARY JUDGMENT; (R)=REQ. FOR RECONSIDERATION; (MD)=MOTION
TO DISMISS; (MR)=MOTION TO REOPEN